全文获取类型
收费全文 | 3425篇 |
免费 | 163篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 139篇 |
妇产科学 | 76篇 |
基础医学 | 482篇 |
口腔科学 | 35篇 |
临床医学 | 283篇 |
内科学 | 840篇 |
皮肤病学 | 77篇 |
神经病学 | 259篇 |
特种医学 | 66篇 |
外科学 | 485篇 |
综合类 | 6篇 |
一般理论 | 1篇 |
预防医学 | 120篇 |
眼科学 | 66篇 |
药学 | 201篇 |
中国医学 | 9篇 |
肿瘤学 | 442篇 |
出版年
2023年 | 17篇 |
2022年 | 33篇 |
2021年 | 55篇 |
2020年 | 46篇 |
2019年 | 58篇 |
2018年 | 77篇 |
2017年 | 55篇 |
2016年 | 53篇 |
2015年 | 86篇 |
2014年 | 129篇 |
2013年 | 120篇 |
2012年 | 215篇 |
2011年 | 221篇 |
2010年 | 154篇 |
2009年 | 137篇 |
2008年 | 219篇 |
2007年 | 218篇 |
2006年 | 221篇 |
2005年 | 210篇 |
2004年 | 219篇 |
2003年 | 197篇 |
2002年 | 190篇 |
2001年 | 75篇 |
2000年 | 43篇 |
1999年 | 47篇 |
1998年 | 39篇 |
1997年 | 40篇 |
1996年 | 42篇 |
1995年 | 33篇 |
1994年 | 22篇 |
1993年 | 17篇 |
1992年 | 37篇 |
1991年 | 24篇 |
1990年 | 26篇 |
1989年 | 26篇 |
1988年 | 23篇 |
1987年 | 23篇 |
1986年 | 21篇 |
1985年 | 24篇 |
1984年 | 17篇 |
1983年 | 10篇 |
1982年 | 16篇 |
1981年 | 3篇 |
1980年 | 13篇 |
1979年 | 10篇 |
1978年 | 10篇 |
1977年 | 5篇 |
1976年 | 5篇 |
1975年 | 6篇 |
1973年 | 2篇 |
排序方式: 共有3598条查询结果,搜索用时 15 毫秒
141.
Gianni Dall'Ara MD PhD Carlo Tumscitz MD Simone Grotti MD Andrea Santarelli MD Marco Balducelli MD Fabio Tarantino MD Francesco Saia MD PhD 《Catheterization and cardiovascular interventions》2021,97(7):E1033-E1042
Even if un to improve long-term prognosis, balloon aortic valvuloplasty (BAV) may be useful in selected patients with symptomatic severe aortic stenosis either as a bridge to surgical or transcatheter valve replacement (aortic valve replacement [AVR] or transcatheter aortic valve implantation [TAVI]) or as a triage strategy for patients with uncertain indications. International guidelines recommend BAV as: a “bridge” to AVR/TAVI, a “trial” in patients with undetermined symptoms, or a “bridge-to-decision” in case of comorbidities. However, in clinical practice, BAV is also used as a palliative measure to improve hemodynamics and quality of life in many patients who are excluded from AVR/TAVI. Finally, BAV is often performed during TAVI to facilitate prosthesis delivery, optimize frame expansion, or for bioprosthetic valve fracture in selected valve-in-valve procedures. Technical innovations, which allow for a mini-invasive approach via transradial access and pacing delivered through the wire, have led to a decrease in complications over time. This review focuses on contemporary BAV with a specific emphasis on new indications, innovative techniques, and specific complex patient subgroups. 相似文献
142.
Luigi Di Biase Jorge Romero Xianfeng Du Sanghamitra Mohanty Chintan Trivedi Domenico G. Della Rocca Kavisha Patel Javier Sanchez Ruike Yang Isabella Alviz Prasant Mohanty Carola Gianni Nicola Tarantino Xiao-Dong Zhang Rodney Horton Amin Al-Ahmad Dhanunjaya Lakkireddy David J. Burkhardt Andrea Natale 《Heart rhythm》2021,18(6):885-893
143.
Marina Macchini Marta Chiaravalli Chiara Pircher Silvia Zanon Umberto Peretti Elena Mazza Maria Maddalena Valente Clara Fugazza Luca Gianni Michele Reni 《Digestive and liver disease》2021,53(1):117-121
Background and AimsOlder patients with metastatic pancreatic adenocarcinoma (MPDAC) are under-represented in clinical trials.MethodsOur single-center, retrospective study enrolled MPDAC patients ≥ 70 treated with chemotherapyResults105 patients were divided in groups based on the received treatments: 44 gemcitabine or capecitabine monotherapy (A), 34 nabpaclitaxel-gemcitabine (B) 27 4-drugs combinations (gemcitabine, cisplatin, capecitabine plus either nab-paclitaxel or epirubicin or docetaxel) (C). Group A: median age was 78 (70–87) and Karnofsky performance status (KPS) ≥80 was found in 84% of patients; Group B: median age 77 (71–84) and KPS ≥ 80 in 88% of patients; Group C: median age 73 (70–78) and KPS ≥ 80 in 93% of patients. Median OS was 7.9, 11.7 and 14.2 months in group A, B and C respectively; 1 and 2-year OS were 27% and 8% in group A; 44% and 5% in group B; 52% and 22% in group C. When lung metastatic only patients were excluded, patients <75 and ≥ 75 had similar OS in group A (6.4 vs 5.6 months) and in group B (12.3 vs 11.1 months). In group B grade 3 thrombocytopenia, fatigue and peripheral neuropathy were more frequent in patients ≥ 75.ConclusionsIn older patients, combination chemotherapy shows acceptable feasibility and promising efficacy. 相似文献
144.
Inge J. van den Hoogen Umberto Gianni Malissa J. Wood Viviany R. Taqueti Fay Y. Lin Sharonne N. Hayes Gudrun M. Feuchtner Alexander R. van Rosendael Nanette K. Wenger Janet Wei C. Noel Bairey Merz Carl J. Pepine Leslee J. Shaw 《JACC: Cardiovascular Imaging》2021,14(5):1053-1062
Women exhibit less burden of anatomic obstructive coronary atherosclerotic disease as compared with men of the same age, but contradictorily show similar or higher cardiovascular mortality rates. The higher prevalence of nonexertional cardiac symptoms and nonobstructive coronary atherosclerotic disease in women may lead to lack of recognition and appropriate management, resulting in undertesting and undertreatment. Leaders in women’s health from the American College of Cardiology’s Cardiovascular Disease in Women Committee present novel imaging cases that may provoke thought regarding the broad clinical spectrum of myocardial infarction and ischemia with nonobstructive coronary arteries in women. These unique imaging approaches are based on the concept of targeting sex-specific differences in acute and stable ischemic heart disease. 相似文献
145.
The soluble ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Cocchi F Fusco D Menotti L Gianni T Eisenberg RJ Cohen GH Campadelli-Fiume G 《Proceedings of the National Academy of Sciences of the United States of America》2004,101(19):7445-7450
Entry of herpes simplex virus (HSV) 1 into cells requires the interaction of HSV gD with herpesvirus entry mediator or nectin1 receptors, and fusion with cell membrane mediated by the fusion glycoproteins gB, gH, and gL. We report that the gD ectodomain in soluble form (amino acids 1-305) was sufficient to rescue the infectivity of a gD-null HSV mutant, indicating that gD does not need to be anchored to the virion envelope to mediate entry. Entry mediated by soluble gD required, in addition to the receptor-binding sites contained within residues 1-250, a discrete downstream portion (amino acids 261-305), located proximal to the transmembrane segment in full-length gD. We named it as profusion domain. The pro-fusion domain was required for entry mediated by virion-bound gD, because its substitution with the corresponding region of CD8 failed to complement the infectivity of gD(-/+) HSV. Furthermore, a receptor-negative gD (gD(Delta6-259)) inhibited virus infectivity when coexpressed with wild-type gD; i.e., it acted as a dominant-negative gD mutant. The pro-fusion domain is proline-rich, which is characteristic of regions involved in protein-protein interactions. P291L-P292A substitutions diminished the gD capacity to complement gD(-/+) HSV infectivity. We propose that gD forms a tripartite complex with its receptor and, by way of the proline-rich pro-fusion domain, with the fusion glycoproteins, or with one of them. The tripartite complex would serve to recruit/activate the fusion glycoproteins and bring them from a fusion-inactive to a fusion-active state, such that they execute fusion of the virion envelope with cell membrane. 相似文献
146.
Perfetti V Ubbiali P Magni M Colli Vignarelli M Casarini S Matteucci P Gianni AM Merlini G 《Bone marrow transplantation》1999,23(4):323-327
In primary systemic amyloidosis, small numbers of bone marrow plasma cells secrete monoclonal light chains that form extracellular fibrils (amyloid) in various organs. Evidence limited to a few cases suggests that rare clonal elements can also be found in the peripheral blood (PB), and this may be relevant in PB stem cell autotransplantation. Since up to 40% of amyloid clones do not synthesize heavy chains, in order to detect tumor cells with high specificity and sensitivity we developed a seminested allele-specific oligonucleotide polymerase chain reaction for tumor light chains. Clone-related sequences were detected in DNA and/or cDNA from the PB cells of eight of 10 patients at diagnosis and from apheretic collections of three of four cases undergoing PB progenitor autotransplantation. Since there are experimental data suggesting that circulating tumor cells may be involved in the growth of the amyloidogenic clone and may be chemoresistant, these findings are relevant to the use of leukapheresis purging strategies for PB progenitor autotransplantation in amyloidosis. 相似文献
147.
Filippi S Luconi M Granchi S Vignozzi L Bettuzzi S Tozzi P Ledda F Forti G Maggi M 《Endocrinology》2002,143(11):4271-4280
Previous binding and contractility studies indicate that oxytocin (OT) receptors are present in rabbit epididymis. To investigate the effect of changing endocrine milieu on OT responsiveness, we induced hypogonadism (hypo) in rabbits with a single administration of a long-acting GnRH analog, triptorelin, and we replaced hypogonadal rabbits with different sex steroids. After 2 months from triptorelin administration, testosterone (T) plasma levels were decreased and OT responsiveness abolished. Administration of T to hypo rabbits restored T plasma levels but not OT sensitivity. Because Western blot analysis indicated that both estrogen receptors and aromatase are expressed in the epididymis, we treated hypo rabbits with estradiol valerate (E2v). E2v not only completely restored OT responsiveness but also even amplified it. Accordingly, Northern and Western blot analysis indicated that both OT receptor gene and protein were strongly induced by E2v but not by T. Surprisingly, also the class I estrogen receptor antagonist, tamoxifen restored OT sensitivity in hypo rabbits. To verify whether endogenous estradiol is involved in the regulation of OT receptor responsiveness, we treated intact rabbits with an aromatase inhibitor, letrozole. Blocking aromatase activity almost completely abolished OT sensitivity. These findings suggest a new function of estrogens in the male: regulation of OT responsiveness in epididymis. 相似文献
148.
Experiments of hybridization between mouse leukemia virus synthetic 3H-DNA probe and mouse main band and satellite DNAs indicate that there is not a higher concentration of viral sequences in the satellite DNA. On the contrary, viral sequences appear to be enriched in the fast renaturing intermediate main band DNA. 相似文献
149.
Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors 总被引:12,自引:0,他引:12
Maggioni AP Anand I Gottlieb SO Latini R Tognoni G Cohn JN;Val-HeFT Investigators 《Journal of the American College of Cardiology》2002,40(8):1414-1421
OBJECTIVES: A subgroup analysis of the Valsartan Heart Failure Trial (Val-HeFT) was performed to evaluate the effects of the angiotensin II receptor blocker, valsartan, in the patients with chronic heart failure (HF) not receiving angiotensin-converting enzyme (ACE) inhibitors. BACKGROUND: The ACE inhibitors reduce mortality and morbidity in patients with HF. Nonetheless, nearly 20% of potentially eligible patients may not be prescribed ACE inhibitors. RESULTS: Val-HeFT was an international, randomized, double-blinded trial that compared valsartan with placebo when added to the prescribed treatment of patients with HF. The two primary end points of the study were all-cause mortality and the composite of all-cause mortality and morbidity (sudden death with resuscitation, hospital admission for HF, or administration of intravenous inotropic or vasodilator drugs for >or=4 h without hospital admission). Of the 5,010 patients enrolled in the trial, 366 (7.3%) were not treated with ACE inhibitors at baseline. The effects of valsartan on the primary and secondary end points of the study were assessed in this subgroup of patients. RESULTS: Both all-cause mortality and combined mortality and morbidity for patients not treated with ACE inhibitors were significantly reduced in the valsartan treatment group compared with the placebo group (17.3% vs. 27.1%, p = 0.017 and 24.9% vs. 42.5%, p < 0.001, respectively). Consistent with the data on clinical events, patients randomized to valsartan showed improvements in physiologic variables, such as ejection fraction, left ventricular internal diameter in diastole, and plasma neurohormone levels. Permanent discontinuation of study treatment because of adverse experiences was comparable between the two groups. CONCLUSIONS: Val-HeFT has provided the first placebo-controlled outcome data demonstrating a favorable effect of an angiotensin receptor blocker on mortality and morbidity in patients with HF not treated with ACE inhibitors. Based on these results, valsartan appears to be an effective therapy in ACE inhibitor-intolerant patients. 相似文献
150.
Gianni Misuri Marco Mancini Iacopo Iandelli Roberto Duranti Loredana Stendardi Francesco Gigliotti Elisabetta Rosi Maria Cristina Ronchi Giorgio Scano 《Pulmonary pharmacology & therapeutics》1997,10(5-6)
Whether, and to what extent, β2-agonists protect against respiratory muscle overloading and breathlessness during bronchoconstriction remains to be defined in patients with asthma. In a double blind placebo-controlled study, 100 μg of fenoterol were administered to six stable asthmatics before a bronchial provocation test, performed by inhaling doubling concentrations of histamine from a Devilbiss 646 nebulizer. We recorded breathing pattern (tidal volume VT, inspiratory time TI, total time of the respiratory cycle TTOT), inspiratory capacity (IC), dynamic pleural pressure swing (Pplsw), total lung resistance (RL) and FEV1. VTwas expressed both in actual values and as % of IC. Changes in VT(%IC) during histamine inhalation reflected changes in dynamic end-inspiratory lung volume (EILV). Pplswwas expressed as % of maximal (the most negative in sign) pleural pressure, obtained under control conditions during a sniff manoeuvre (Pplsn). Pplsw(%Pplsn) is an index of inspiratory muscle effort. The test ended when the concentration of histamine which caused a decrease in FEV1of ≥40% post-saline was reached. Dyspnoea rating was scored by a modified Borg scale. At the ultimate degree of bronchoconstriction (UDB) with histamine: (i) decrease in FEV1was similar after placebo and fenoterol, while increase in RLwas lower after fenoterol (P<0.005); (ii) VT(%IC) increased less after fenoterol (P<0.027); (iii) increases in Pplsw(%Pplsn) was lower after fenoterol (P<0.001); (iv) ΔBorg (from saline) was lower (P<0.01) after fenoterol; (v) differences in ΔBorg, from placebo to fenoterol, related to concurrent changes in VT(%IC) (r2=0.67). In conclusion, at UDB 100 μg of fenoterol produced a beneficial effect on the degree of inspiratory muscle loading and breathlessness, an effect greater than it would be expected from measuring FEV1alone. 相似文献